Univest
Univest
  • Markets

Achyut Health Q1 FY27 Results: Revenue Flat at Rs 3 Crore, PAT Grows 28% to Rs 14 Lakh

  • August 14, 2026
  • Posted by: Neeraj Pandey
  • Category: Market
No Comments
Achyut Health Q1 FY27 Results: Revenue Flat at Rs 3 Crore, PAT Grows 28% to Rs 14 Lakh

Achyut Health Q1 FY27: Revenue Rs 3 Cr (+1.14% YoY). PAT Rs 0.14 Cr (+27.77%). Gross profit Rs 0.15 Cr vs Rs 0.07 Cr (+127.18%). CMP Rs 6.86 on Aug 13.

Quick Answer

Achyut Health posted a resilient Q1 FY27 performance, with standalone revenue essentially flat at Rs 3 crore and gross profit more than doubling to Rs 0.15 crore from Rs 0.07 crore. PAT grew 27.77% to Rs 0.14 crore from Rs 0.11 crore in Q1 FY26. Achyut Health Q1 FY27 results show consistent small-scale growth with improving profitability at a modest healthcare services company.

Achyut Health Q1 FY27 results showed the healthcare services company maintaining stable standalone revenue of Rs 3 crore, up just 1.14% from Rs 3 crore in Q1 FY26. The small company is growing its revenue base incrementally while improving its profitability metrics through better service delivery efficiency.

The Achyut Health Q1 FY27 results demonstrated meaningful profitability improvement on flat revenue. Gross profit more than doubled from Rs 0.07 crore to Rs 0.15 crore, and PAT grew 28% to Rs 0.14 crore. Though absolute numbers are very small, the proportionate improvement indicates that the company is enhancing its service margins through better patient mix, cost management, or higher-value healthcare service delivery.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Achyut Health Q1 FY27 Financial Highlights
  • Achyut Health Q1 FY27 Performance Analysis
  • Key Business Factors in Q1 FY27
    • Healthcare Service Margin Improvement
    • Small-Scale Healthcare Operations
    • PAT Conversion Efficiency
  • Dividend Details
  • FY27 Outlook
  • Achyut Health Stock Performance
  • Key Risks
    • Small Revenue Scale Vulnerability
    • Healthcare Regulatory Compliance
    • Competition from Larger Healthcare Networks
  • Conclusion
  • Frequently Asked Questions on Achyut Health Q1 FY27 Results
    • When were Achyut Health Q1 FY27 results announced?
    • What was Achyut Health’s revenue in Q1 FY27?
    • What was Achyut Health’s PAT in Q1 FY27?
    • How did Achyut Health more than double its gross profit on flat revenue in Q1 FY27?
    • Did Achyut Health declare a dividend for Q1 FY27?
    • What is the outlook for Achyut Health after Q1 FY27 results?
    • Is Achyut Health a good investment after Q1 FY27 results?

Achyut Health Q1 FY27 Financial Highlights

Metric Q1 FY27 (Rs Crore) Q1 FY26 (Rs Crore) YoY Change
Revenue 3.00 3.00 +1.14%
Gross Profit 0.15 0.07 +127.18%
Net Profit / PAT 0.14 0.11 +27.77%

Achyut Health Q1 FY27 Performance Analysis

Use the Univest Screener to track Achyut Health live financials and Q1 FY27 results

Achyut Health Q1 FY27 results show a small healthcare company demonstrating consistent improvement in its profitability metrics. While the absolute scale is modest with Rs 3 crore revenue, the doubling of gross profit and 28% PAT growth on flat revenue is a positive signal of improving unit economics in the healthcare services operations.

The gross margin improvement in Achyut Health Q1 FY27 results from approximately 2.3% (Rs 0.07 Cr on Rs 3 Cr) to 5% (Rs 0.15 Cr on Rs 3 Cr) on flat revenue indicates better service delivery efficiency, possibly through reduced direct costs in healthcare consumables, better capacity utilisation at the clinical facility, or an improved patient or service mix.

For a small healthcare company like Achyut Health, consistent profitability improvement, even at small absolute levels, is important for demonstrating business model viability. The Q1 FY27 results trajectory of growing margins on stable revenue sets a positive foundation for future scale.

Revenue growth at Achyut Health is modest at 1.14%, but the company appears to be focusing on improving the quality and profitability of existing healthcare services before aggressively expanding patient or service volumes.

Key Business Factors in Q1 FY27

Healthcare Service Margin Improvement

Gross profit more than doubling in Achyut Health Q1 FY27 results on flat revenue indicates improved service delivery efficiency. Healthcare companies can improve margins through better formulary management, reduced medical consumable waste, improved staff productivity, or better insurance billing and collections.

Small-Scale Healthcare Operations

At Rs 3 crore quarterly revenue, Achyut Health operates a small healthcare facility or diagnostic centre. Growth at this scale requires either expanding the patient base, adding new services, or improving average revenue per patient — all of which are being pursued incrementally.

PAT Conversion Efficiency

PAT of Rs 0.14 crore on gross profit of Rs 0.15 crore in Achyut Health Q1 FY27 results indicates that the company has minimal below-gross-profit costs, suggesting a very lean operating structure appropriate for a small healthcare services provider.

Dividend Details

Achyut Health has not declared a dividend for Q1 FY27. At the current PAT scale of Rs 14 lakh per quarter, the company retains earnings for operational investment and service expansion.

FY27 Outlook

The FY27 outlook for Achyut Health is constructive at a small scale. India’s healthcare sector benefits from rising health awareness, expanding insurance coverage, and the government’s focus on primary healthcare access. These structural tailwinds support gradual revenue and profitability improvement for small healthcare service providers.

Key catalysts for Achyut Health’s growth from Q1 FY27 results include adding new diagnostic services, expanding patient capacity, or entering new geographic markets within its operating region.

Achyut Health Stock Performance

Download the Univest iOS App or Univest Android App to track Achyut Health share price live and stay updated on quarterly results.

Achyut Health shares traded at Rs 6.86 on August 13, 2026, down 2.70% on the day. The very low share price and small scale of the business make this a highly speculative investment. Investors should thoroughly research the company’s healthcare service portfolio and growth plans before any consideration of investment.

Key Risks

Small Revenue Scale Vulnerability

At Rs 3 crore quarterly revenue, Achyut Health is extremely sensitive to patient footfall changes, seasonal demand variations, or the loss of any significant institutional healthcare contract. These factors could cause material revenue swings from Q1 FY27 results.

Healthcare Regulatory Compliance

Healthcare service providers in India face regulatory requirements from state medical councils, NABH, and other authorities. Any compliance issues could disrupt operations and impact revenue from Q1 FY27 results levels.

Competition from Larger Healthcare Networks

India’s healthcare market is increasingly dominated by large hospital chains and diagnostic networks with better brand recognition and scale advantages. Small independent healthcare providers like Achyut Health face competitive pressure from these better-resourced players.

Conclusion

Achyut Health Q1 FY27 results show consistent improvement in profitability on flat revenue, with gross profit more than doubling to Rs 0.15 crore and PAT growing 28% to Rs 0.14 crore. While scale remains very small, the trajectory is positive.

Investors should assess Achyut Health’s healthcare service portfolio and growth strategy before considering investment at this very early stage. The company demonstrates operational improvement but needs significant revenue scaling to become a meaningful investment case. Consult a SEBI-registered advisor.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Achyut Health Q1 FY27 Results

When were Achyut Health Q1 FY27 results announced?

Ans. Achyut Health Q1 FY27 results were announced on August 13, 2026, covering the April to June 2026 quarter on a standalone basis.

What was Achyut Health’s revenue in Q1 FY27?

Ans. Achyut Health reported standalone revenue of Rs 3 crore in Q1 FY27, up 1.14% from Rs 3 crore in Q1 FY26.

What was Achyut Health’s PAT in Q1 FY27?

Ans. Achyut Health’s net profit (PAT) was Rs 0.14 crore in Q1 FY27, up 27.77% from Rs 0.11 crore in Q1 FY26.

How did Achyut Health more than double its gross profit on flat revenue in Q1 FY27?

Ans. Achyut Health Q1 FY27 results show gross profit improving from Rs 0.07 crore to Rs 0.15 crore on flat revenue, reflecting better healthcare service delivery efficiency, improved patient mix, or reduced direct costs in consumables and medical supplies.

Did Achyut Health declare a dividend for Q1 FY27?

Ans. Achyut Health has not declared a dividend for Q1 FY27.

What is the outlook for Achyut Health after Q1 FY27 results?

Ans. The FY27 outlook is gradually positive with improving margins. Healthcare sector tailwinds support growth, but revenue scaling from the small Rs 3 crore base requires deliberate expansion in services and patient reach.

Is Achyut Health a good investment after Q1 FY27 results?

Ans. Achyut Health Q1 FY27 results show positive progress at a very small scale. This is a speculative investment at this stage. Consult a SEBI-registered advisor.



News
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply